Skip to content

Evaluation of Onefit Scleral Lenses in the Mangement of Dry Eye

Evaluation of Onefit Scleral Lenses in the Mangement of Dry Eye

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05973409
Enrollment
46
Registered
2023-08-02
Start date
2022-09-26
Completion date
2023-08-15
Last updated
2026-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Brief summary

This study is being conducted to determine if scleral lenses treated with Hydra-PEG improve comfort and dryness.

Detailed description

The objective of the study is to determine if scleral lenses with and scleral lenses without Hydra-PEG treatment provide positive improvement in ocular comfort and dryness scores. The effect of the study lenses and the treatment, will be compared in a group of symptomatic soft lens wearers, and also in a group of symptomatic non contact lens wearers. The primary outcome variable for this study is "overall ocular comfort" reported at the screening visit for the habitual vision correction, and at the 4-week follow-up visits for each of the two study lenses. using a 0-10 scale (0.5 steps).

Interventions

scleral lens with and without hydra-peg treatment

Sponsors

CooperVision International Limited (CVIL)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Masking description

At the fitting visit, only uncoated lenses will be used to determine the parameters of the lenses to be ordered. At both dispense visits, participants and investigators will be masked to the lens type dispensed. In order to achieve this, unmasked study personnel will determine the order of lens wear according to the randomization schedule and they will not share the lens labels or packs with the investigator. Instead, the lenses will be transferred to an unmarked case/container prior to being provided at the Dispense visit.

Eligibility

Sex/Gender
ALL
Age
17 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Are at least 17 years of age and have full legal capacity to volunteer; 2. Have read and signed an information consent letter; 3. Are willing and able to follow instructions and maintain the appointment schedule; 4. Agree to wear the study scleral lenses for at least 8 hours per day, 5 days a week; 5. Have a refraction between +20.00 and -20.00D and spectacle astigmatism of no more than -3.00DC in each eye; 6. Have best corrected visual acuity of 20/40 or better in each eye with the study lenses; 7. Demonstrate an acceptable fit with the study lenses; 8. Have no active ocular disease or inflammation; 9. Group 1: Habitual wearer of frequent replacement or daily disposable soft lenses; 10. Group 2: Have not worn contact lenses for 6 months; 11. Group 1: Contact lens wearers should score ≥12 on CLDEQ-8; 12. Group 2: Non contact lens wearers should score ≥13 on OSDI.

Exclusion criteria

1. Are participating in any concurrent clinical or research study, or have done so within the past 30 days; 2. Cannot achieve a successful lens fit or vision with the study lens; 3. Have been diagnosed with keratoconus or corneal distortion; 4. Have any known active\* ocular condition, disease and/or infection; 5. Have a systemic or ocular condition that in the opinion of the investigator may affect a study outcome variable e.g. pingueculae; 6. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; 7. Group 2: Non-contact lens wearers who score ≥33 on OSDI and also demonstrate either corneal staining ≥3 (Oxford scale) or non-invasive tear break-up time ≤3 seconds#; 8. Have known sensitivity to the diagnostic sodium fluorescein to be used in the study; 9. Are pregnant, lactating or planning a pregnancy\^ at the time of enrolment, by self report; 10. Have undergone refractive error surgery; 11. Are listed on the Delegation Log for this study.

Design outcomes

Primary

MeasureTime frameDescription
overall ocular comfort4 weeksreported at the screening visit for the habitual vision correction, and at the 4-week follow-up visits for each of the two study lenses. using a 0-10 scale (0.5 steps)

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORLyndon Jones, PhD

Director, Centre for Ocular Research and Education

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 18, 2026